Kaoru Furihata, Atsushi Kurabayashi, Waka Iwashita, Noriko Wada, Makoto Toi, Jo Yoshimichi, Hideo Fukuhara, Keiji Inoue, Mutsuo Furihata. Poorly Differentiated Carcinoma with only Clear Glandular Differentiation Arising from the Bladder Trigone: A Case of Adenocarcinoma or Urothelial Carcinoma?. The Keio journal of medicine. 2025
Shinkuro Yamamoto, Shingo Ashida, Tomoya Nao, Kaho Murakami, Ryohei Iga, Tsutomu Shimamoto, Hideo Fukuhara, Nobutaka Shimizu, Satoshi Fukata, Atsushi Kurabayashi, et al. Comprehensive genomic profiling of primary bladder mucinous adenocarcinoma, a rare genitourinary cancer: A case report. Urology Case Reports. 2025. 58. 102892-102892
Atsushi Kurabayashi, Hideo Fukuhara, Kaoru Furihata, Waka Iwashita, Mutsuo Furihata, Keiji Inoue. Photodynamic Diagnosis and Therapy in Non-Muscle-Invasive Bladder Cancer. Cancers. 2024. 16. 13. 2299-2299
Atsushi Kurabayashi, Waka Iwashita, Kaoru Furihata, Hideo Fukuhara, Keiji Inoue. Potential effect of the non-neuronal cardiac cholinergic system on hepatic glucose and energy metabolism. Frontiers in Cardiovascular Medicine. 2024. 11. 1381721
Shingo Ashida, Chiaki Kawada, Hiroko Tanaka, Atsushi Kurabayashi, Ken-ichi Yagyu, Shuji Sakamoto, Kazuhiro Maejima, Satoru Miyano, Masanori Daibata, Hidewaki Nakagawa, et al. Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer. The Prostate. 2024
Remote ischemic preconditioning suppresses diabetic nephropathy via podocyte protection
(IDF World Diabetes Congress 2025 2025)
Effect of RIPC on sub-diabetic hepatic fat deposition and fatty liver tissue response
(IDF World Diabetes Congress 2025 2025)
Remote preconditioning increases glucose utilization via hepatic glucose transporter-4 and improves hepatosteatosis.
(IDF-WPR Congress 2023, Kyoto)
Immunohistochemical study of CAFs in the mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013 derived organoid
(2nd JCA-AACR Precision Cancer Medicine International Conference, kyoto)
Remote preconditioning suppresses diabetic ketosis by increasing glucose utilization via hepatic glucose transporter-4.
(International Diabetes Federation (IDF) Congress 2022, Lisbon 2022)